Caturkarda Depo Bangunan Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Caturkarda Depo Bangunan Tbk. trades at Rp250 (market cap 1.67T, 208.3K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Caturkarda Depo Bangunan Tbk. is far larger — about 5.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 208.3K). Which is the better fit depends on your goals.
| DEPO | DGNS | |
|---|---|---|
Market Cap | 1.67T | 310.75B |
Volume | 208.3K | 963.6K |
Lot | 2.08K | 9.64K |
Turnover | 51.18M | 217.67M |
Average Price | 245.71 | 225.89 |
Value | 51.18M | 217.67M |
Indicative Equilibrium Price | 250 | 226 |
Indicative Equilibrium Volume | 300 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Caturkarda Depo Bangunan Tbk (the “Company”) was established based on Notarial Deed No. 5 dated January 3, 1996 of Public Notary Mrs. Poerbaningsih Adi Warsito, S.H., a Notary in Jakarta. The Company commenced its commercial operations in 1996.
Read more on DEPO →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →